NR3C1 and type 2 diabetes mellitus: Indeed, in T2DM patients, an increased (even though still within the normal range) cortisol secretion is present, particularly in those affected with the diabetic complications [13] and the different glucocorticoid receptor (GR) gene polymorphisms have been found to potentially influence the disease control [150].